PUBLIC COMPANY
saveDianthus Therapeutics Inc
updated 17d ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
- phase2A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)
- phase3A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- phase2A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy
🐶 Hiring Signal
News
- Sanofi stops immune drug trial in latest research setbackThe failure adds to a series of mixed or negative readouts and leaves in doubt the future of a therapy Sanofi has viewed as a potential blockbuster.biopharma_dive · 2mo ago
comments(0)
5-min edit window · permanent after that